TRINOVIN Trademark
Trademark Overview
On Friday, August 28, 1998, a trademark application was filed for TRINOVIN with the United States Patent and Trademark Office. The USPTO has given the TRINOVIN trademark a serial number of 75544637. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 11, 2015. This trademark is owned by Novogen Research Pty Limited. The TRINOVIN trademark is filed in the Pharmaceutical Products category with the following description:
non-prescription pharmaceutical preparations containing phytoestrogens, their metabolites, and/or glucan for the prevention and treatment of cancer and other hormone related diseases of the breast, prostate, uterus, ovaries, skin, bowel and cardiovascular system, including menopausal symptoms, BPH, osteoporosis, endometriosis, fibroids, mastitis, UV induced damages, cognitive function, arthritis, and cataracts; homeopathic preparations and herbal extracts derived from phytoestrogen-containing plants including their metabolites, for the prevention and treatment of cancer and other hormone related diseases of the breast, prostate, uterus, ovaries, skin, bowel and cardiovascular systems including menopausal symptoms, BPH, osteoporosis, endometriosis, fibroids, mastitis, UV induced damage, cognitive function, arthritis and cataracts specifically excluding prescription and non-prescription pharmaceutical preparations for the treatment, relief, or alleviation of coughs, colds, allergy sympto...
General Information
Serial Number | 75544637 |
Word Mark | TRINOVIN |
Filing Date | Friday, August 28, 1998 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, December 11, 2015 |
Registration Number | 2947025 |
Registration Date | Tuesday, May 10, 2005 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 9, 2001 |
Trademark Statements
Goods and Services | non-prescription pharmaceutical preparations containing phytoestrogens, their metabolites, and/or glucan for the prevention and treatment of cancer and other hormone related diseases of the breast, prostate, uterus, ovaries, skin, bowel and cardiovascular system, including menopausal symptoms, BPH, osteoporosis, endometriosis, fibroids, mastitis, UV induced damages, cognitive function, arthritis, and cataracts; homeopathic preparations and herbal extracts derived from phytoestrogen-containing plants including their metabolites, for the prevention and treatment of cancer and other hormone related diseases of the breast, prostate, uterus, ovaries, skin, bowel and cardiovascular systems including menopausal symptoms, BPH, osteoporosis, endometriosis, fibroids, mastitis, UV induced damage, cognitive function, arthritis and cataracts specifically excluding prescription and non-prescription pharmaceutical preparations for the treatment, relief, or alleviation of coughs, colds, allergy symptoms, and diseases of the larynx, pharynx, nose, and lungs, and antihistamine and decongestant pharmaceutical preparations |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, December 11, 2015 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | PHARM-A-CARE (AUSTRALIA) PTY LIMITED |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 99 - Other |
Address | NORTH SYDNEY, NEW SOUTH WALES 2060 AU |
Party Name | Novogen Research Pty Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | New South Wales, 2113 AU |
Party Name | Novogen Research Pty Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New South Wales, 2113 AU |
Party Name | Novogen Research Pty Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New South Wales, 2113 AU |
Trademark Events
Event Date | Event Description |
Friday, December 11, 2015 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
Wednesday, November 9, 2011 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, June 7, 2011 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Tuesday, June 7, 2011 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Monday, May 9, 2011 | TEAS SECTION 8 & 15 RECEIVED |
Tuesday, May 10, 2005 | REGISTERED-PRINCIPAL REGISTER |
Friday, December 10, 2004 | OPPOSITION TERMINATED NO. 999999 |
Thursday, September 16, 2004 | OPPOSITION TERMINATED NO. 999999 |
Thursday, September 16, 2004 | OPPOSITION TERMINATED NO. 999999 |
Thursday, September 16, 2004 | OPPOSITION DISMISSED NO. 999999 |
Wednesday, June 20, 2001 | OPPOSITION INSTITUTED NO. 999999 |
Thursday, January 25, 2001 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, January 9, 2001 | PUBLISHED FOR OPPOSITION |
Friday, December 8, 2000 | NOTICE OF PUBLICATION |
Thursday, March 16, 2000 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 1, 2000 | EXAMINER'S AMENDMENT MAILED |
Wednesday, March 1, 2000 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Wednesday, February 16, 2000 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, February 10, 2000 | EXAMINER'S AMENDMENT MAILED |
Tuesday, January 18, 2000 | FINAL REFUSAL MAILED |
Thursday, October 21, 1999 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 26, 1999 | NON-FINAL ACTION MAILED |
Tuesday, April 13, 1999 | ASSIGNED TO EXAMINER |
Friday, April 9, 1999 | ASSIGNED TO EXAMINER |